MGEN nice https://www.marketwatch.com/press-release/miragen-announces-encouraging-preclinical-safety-and-efficacy-data-for-its-next-generation-mir-29-replacement-product-candidate-intended-for-the-treatment-of-idiopathic-pulmonary-fibrosis-2020-06-22?siteid=bigcharts&dist=bigcharts&tesla=y